Veronika A. Szalai joined NIST in 2010 and is currently the leader of the Biomedical Microtechnologies Group. She received an A.B. in Chemistry from Bryn Mawr College and a Ph.D. in Inorganic Chemistry from Yale University, where her thesis work centered on biophysical chemistry measurements of water oxidation chemistry in photosynthesis. After completing post-doctoral work on DNA electrochemistry at the University of North Carolina at Chapel Hill, Veronika advanced to the rank of tenured associate professor in the Department of Chemistry & Biochemistry at the University of Maryland Baltimore County. During that time, she and her group elucidated the biophysical chemistry of copper and the amyloid peptide of Alzheimer's disease and developed methods to create guanine quadruplex-based DNA nanostructures. Her laboratory now focuses on advanced electron paramagnetic resonance spectroscopy and instrumentation development for measurements of biological nanostructures and development of tools for in operando reactivity measurements of nanomaterials.